Agenus Newsroom

Agenus Analyst Ratings

BenzingaAug 14 09:30 ET

B. Riley Adjusts Price Target on Agenus to $18 From $42, Maintains Buy Rating

MT NewswiresAug 14 07:59 ET

B.Riley Financial Maintains Agenus(AGEN.US) With Buy Rating, Cuts Target Price to $18

Moomoo NewsAug 13 14:31 ET

Agenus Downgraded at Baird After FDA Feedback on Cancer Drug

Seeking AlphaJul 19 09:12 ET

HC Wainwright Downgrades Agenus to Neutral From Buy, Adjusts Price Target to $9 From $40

MT NewswiresJul 19 07:08 ET

HC Wainwright & Co. Downgrades Agenus to Neutral, Lowers Price Target to $9

BenzingaJul 18 12:38 ET

Agenus Analyst Ratings

BenzingaJul 18 12:37 ET

Agenus Analyst Ratings

BenzingaJun 28 13:31 ET

Buy Rating Affirmed for Agenus Amid Promising Colorectal Cancer Study Results

TipRanksMay 24 14:00 ET

Agenus Analyst Ratings

BenzingaMay 24 07:18 ET

Analysts Offer Insights on Healthcare Companies: Agenus (AGEN), Merus (MRUS) and Iovance Biotherapeutics (IOVA)

TipRanksMay 24 06:25 ET

Analysts Offer Insights on Healthcare Companies: Arvinas Holding Company (ARVN), Eledon Pharmaceuticals (ELDN) and Agenus (AGEN)

TipRanksMay 8 08:41 ET

Agenus Analyst Ratings

BenzingaMay 7 14:08 ET

Analysts Offer Insights on Healthcare Companies: Biomea Fusion (BMEA), Repligen (RGEN) and Agenus (AGEN)

TipRanksMay 3 07:50 ET

Agenus Analyst Ratings

BenzingaMar 18 09:24 ET

B. Riley Securities Trims Agenus' Price Target to $5 From $6 After Model Update, Maintains Buy Rating

MT NewswiresMar 18 07:50 ET

Agenus Analyst Ratings

BenzingaMar 14 11:04 ET

Agenus's Promising Botensilimab Leads to Buy Rating From Analyst Mayank Mamtani

TipRanksMar 6 14:35 ET

Analysts Are Bullish on Top Healthcare Stocks: Agenus (AGEN), Zivo Bioscience (ZIVO)

TipRanksJan 25 08:00 ET

Analysts Offer Insights on Healthcare Companies: Agenus (AGEN), Regeneron (REGN) and Warby Parker (WRBY)

TipRanksJan 22 16:00 ET